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Abstract
Background: Kawasaki disease (KD) is a systemic vasculitis of unknown etiology. The innate immune system is involved in
its pathophysiology at the acute phase. We have recently established a novel murine model of KD coronary arteritis by oral
administration of a synthetic microbe-associated molecular pattern (MAMP). On the hypothesis that specific MAMPs exist in
KD sera, we have searched them to identify KD-specific molecules and to assess the pathogenesis.
Methods: We performed liquid chromatography-mass spectrometry (LC-MS) analysis of fractionated serum samples from
117 patients with KD and 106 controls. Microbiological and LC-MS evaluation of biofilm samples were also performed.
Results: KD samples elicited proinflammatory cytokine responses from human coronary artery endothelial cells (HCAECs). By
LC-MS analysis of KD serum samples collected at 3 different periods, we detected a variety of KD-specific molecules in the
lipophilic fractions that showed distinct m/z and MS/MS fragmentation patterns in each cluster. Serum KD-specific
molecules showed m/z and MS/MS fragmentation patterns almost identical to those of MAMPs obtained from the biofilms
formed in vitro (common MAMPs from Bacillus cereus, Yersinia pseudotuberculosis and Staphylococcus aureus) at the 1st study
period, and from the biofilms formed in vivo (common MAMPs from Bacillus cereus, Bacillus subtilis/Bacillus cereus/Yersinia
pseudotuberculosis and Staphylococcus aureus) at the 2nd and 3rd periods. The biofilm extracts from Bacillus cereus, Bacillus
subtilis, Yersinia pseudotuberculosis and Staphylococcus aureus also induced proinflammatory cytokines by HCAECs. By the
experiments with IgG affinity chromatography, some of these serum KD-specific molecules bound to IgG.
Conclusions: We herein conclude that serum KD-specific molecules were mostly derived from biofilms and possessed
molecular structures common to MAMPs from Bacillus cereus, Bacillus subtilis, Yersinia pseudotuberculosis and Staphylococcus
aureus. Discovery of these KD-specific molecules might offer novel insight into the diagnosis and management of KD as well
as its pathogenesis.
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Introduction
The etiology of Kawasaki disease (KD) remains unknown,
however, KD has long been considered to be caused by an
infectious agent, because of its characteristics of the symptoms, age
distribution, seasonality, occurrence of community outbreaks and
epidemic cycles. On the other hand, no consistently recoverable
agents, lack of person-to-person transmission or a common
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contagious source, and paucity of case clusters in families, schools
or nurseries are supportive of a non-infectious cause for KD [1–3].
Temporal clustering and marked seasonality in KD occurrence in
Japan, Hawaii and San Diego also suggest a wind-borne
environmental trigger for this disease [4].
KD is also characterized by marked elevations of serum levels of
proinflammatory cytokines and chemokines [2] and the activation
of the innate immune system [5–7]. We have established a novel
murine model of KD coronary arteritis by oral administration of
FK565, which functions as a synthetic microbe-associated
molecular pattern (MAMP) and a ligand to one of the innate
immune receptors, nucleotide-binding oligomerization domain-
containing protein (NOD) 1 [8]. In this report, we performed
liquid chromatography-mass spectrometry (LC-MS) analysis of
KD sera to find out KD-specific molecules and demonstrated that
serum KD-specific molecules were closely linked to MAMPs in the
biofilms.
Materials and Methods
Study subjects
All patients enrolled in this study were admitted to Kyushu
University Hospital, Fukuoka Children’s Hospital and Medical
Center for Infectious Diseases, Kawasaki Medical School Hospital
or Kurashiki Central Hospital between June 2010 and March
2014. The study subjects consisted of 117 patients with KD
(median age, 21 months; range 3–96 months; male/female, 65/
52), 101 controls with other febrile illnesses (DC: median age, 16
months; range 0–121 months; male/female, 61/40), and 5 normal
controls (NC: median age, 6 months; range 3–39 months; male/
female, 1/4). A diagnosis of KD was made according to the
Diagnostic Guidelines of KD [9]. The Ethical Committee of
Kyushu University approved the study. Written informed consent
was obtained from all guardians. The 1st study subjects (samples
were collected mostly between July 2011 and February 2012)
consisted of 43 patients with KD, 41 controls with DC (respiratory
syncytial virus infection: n= 4, influenza A virus infection: n= 7,
adenovirus infection: n= 2, exanthema subitum: n= 5, varicella:
n= 2, bacteremia: n= 2, pneumonia: n= 6, tonsillitis: n= 1,
lymphadenitis: n= 5, cellulitis: n= 1, urinary tract infection:
n= 1, gastritis: n= 5), and 5 NC. The 2nd (mostly between May
2012 and July 2013) and 3rd (mostly between November 2013 and
March 2014) study subjects consisted of 41 KD patients and 30
DC controls (respiratory syncytial virus infection: n= 8, influenza
A virus infection: n= 4, adenovirus infection: n= 2, exanthema
subitum: n= 2, herpetic stomatitis: n= 1, pneumonia: n= 5,
bronchitis: n= 2, upper respiratory infection: n= 1, tonsillitis:
n= 2, deep neck abscess: n= 1, acute otitis media: n= 1, urinary
tract infection: n= 1), and 33 KD patients and 30 DC controls
(respiratory syncytial virus infection: n= 8, influenza A virus
infection: n= 1, adenovirus infection: n= 1, pneumonia: n= 6,
bronchitis: n= 1, upper respiratory infection: n= 4, tonsillitis:
n= 2, lymphadenitis: n= 1, sinusitis: n= 1, acute otitis media:
n= 1, urinary tract infection: n= 2, gastritis: n= 2), respectively.
Sample collection
Blood samples were collected at the time of routine examina-
tions before and after high-dose intravenous immunoglobulin
(IVIG) therapy, and after resolution of symptoms. The sera were
separated by centrifugation and stored at 230uC until the analysis.
Routine bacterial cultures were performed with throat, tongue,
nasal and rectal swabs. Biofilms from teeth, tongue, nasal cavity, or
rectum (stool) were collected by cotton swabs or interdental
brushes (for teeth). These swabs or brushes were suspended in
double distilled water (ddH2O) immediately and stored at 230uC
until the analysis. Simultaneous collection of biofilm and serum
samples was performed at 2nd (n= 12, mostly October-December,
2012) and 3rd (n= 11, mostly January-February, 2014) study
periods.
Lipid extraction
Serum samples or other specimens were separated into
lipophilic and hydrophilic fractions by Folch method [10] or ethyl
acetate extraction [11,12]. As for Folch method [10], 100 mL of
serum was acidified to pH5 with acetic acid and mixed with 2:1
chloroform-methanol mixture (v/v) to a final volume 300 mL. The
mixture was shaken and centrifuged at 3000 rpm for 10 minutes,
and the bottom lipophilic layer and upper hydrophilic layer were
collected and evaporated. The lipophilic pellet was dissolved in
5 mL of chloroform, 5 mL of dimethyl sulfoxide (DMSO), and
40 mL of ddH2O and hydrophilic pellet was in 50 mL of ddH2O.
As for ethyl acetate extraction [11,12], 100 mL of serum was mixed
with the same volume of ethyl acetate. After centrifugation, the
upper lipophilic layer including the interface and the bottom
Figure 1. Whole and fractionated serum samples from KD
patients induce cytokine production in HCAECs. The production
of IL-8 by HCAECs was measured in triplicate after 24-hour stimulation
with whole sera or lipophilic and hydrophilic fractions from KD patients
(n = 6), DC controls (n = 5; pneumonia; n = 2, influenza A virus infection;
n = 1, adenovirus infection; n = 1 and urinary tract infection; n = 1), or NC
subjects (n = 5). Lipophilic and hydrophilic fractions were separated by
ethyl acetate extraction. The bottom and top edges of the box plot
correspond to the 25th and 75th percentiles, respectively. The
horizontal line inside the box represents the median of the distribution.
The whiskers indicate the 10th and 90th percentiles. **P,0.01; ***P,
0.001 (Welch’s t-test).
doi:10.1371/journal.pone.0113054.g001
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hydrophilic layer were transferred, evaporated, and dissolved in
50 mL of 20% methanol (lipophilic layers), and in 100 mL ddH2O
(hydrophilic layers) for cell stimulation, respectively. Since the
human coronary artery endothelial cell (HCAEC)-stimulatory
activities of KD serum samples were not stable after extraction
with Folch method, we used ethyl acetate instead of chloroform.
For LC-MS, lipophilic fractions were dissolved in 100% methanol.
Other samples were also mixed with the same volumes of ethyl
acetate, and centrifuged. Upper lipophilic layers including
interfaces were collected, evaporated and dissolved in 100%
methanol. To each sample, dibutyl hydroxytoluene was added at a
final concentration of 1.0% as an antioxidant [13].
Cell stimulation
HCAECs (purchased from Lonza and no mycoplasma contam-
ination) were cultured in EBM-2 medium with EGM-2MV
(Lonza) in a 5% CO2 incubator at 37uC. These cells, between
passages 5 and 7, were suspended and seeded into 75 cm2 flask.
After passage, HCAECs were introduced in a 96 well plate (36103
cells/well). On the following day, the medium was changed and
the supernatants were collected for assay 24 hours after stimula-
tion.
Cytokine assay
The concentrations of IL-8, IL-6, IL-1b, TNF-a, IL-12p70, and
IL-10 in culture supernatants were measured by EC800 cell
analyzer (Sony Corporation) with a BD Cytometric Bead Array
human inflammation kit (BD Biosciences) [8]. We performed the
experiments at least 3 times.
LC- MS analysis
Samples were analyzed by high performance liquid chroma-
tography (HPLC, Agilent 1200 HPLC instrument, Agilent
Technologies) on Dionex Acclaim surfactant column (3 mm,
120A˚, 2.16150 mm, DIONEX) and MS (Esquire 6000 electro-
spray ionization: ESI, Bruker Daltonics). The mobile phases were
H2O with 0.1% formic acid (eluent A) and acetonitril with 0.1%
formic acid (eluent B). They were delivered at a flow rate of
0.2 ml/min and the column was operated at 25uC. The gradient
was as follows: 0–3 min. 20% B, 3–12 min. 20–100% B, 12–
70 min. 100% B. The injection volume to the system was fixed at
10 ml. The column eluent was connected to MS. The ESI-MSn
spectrum conditions were optimized in the negative-ion mode with
the conditions as follows: nebulizer gas, 30.0 psi; drying gas, flow 8
l/min; dry temperature 330uC; high voltage (HV) capillary,
4500 V; HV end plate offset, 2500 V; target ion trap, 30000; scan
range 100–3000 m/z. The width for targeted precursor ions was
set at 4 m/z.
Biofilm extraction from glass slides
After removing the medium, the culture tube and glass slides
were washed once with PBS and vortexed in the presence of ethyl
acetate. The ethyl acetate was transferred and evaporated, and the
pellet was dissolved in 100% methanol. Details were described in
Text S1 in File S1.
IgG affinity chromatography
Columns used included human polyclonal IgG-conjugated
Sepharose 6 Fast (GE Healthcare Life Science), human IgG
F(ab9)2 fragment-conjugated agarose (ROCKLAND), human IgG
Fc fragment full length protein (Abcam)-coupled to cyanogen-
bromide (CNBr) Sepharose 4B (GE Healthcare Life Science),
mouse monoclonal IgG against a specific antigen (Myc-tag)-
conjugated agarose (MBL), rabbit monoclonal IgG against a
specific antigen (Phospho-Met (Tyr1234/1235) (D26) XP)-conju-
gated sepharose (Cell Signaling), and inactivated CNBr Sepharose
4B (GE Healthcare Life Science). Coupling to and inactivation of
CNBr Sepharose 4B were performed according to the manufac-
turer’s instructions. Each column was washed once with 10
volumes of PBS with 0.05% Tween20, and twice with 20 volumes
of PBS. Biofilms extracts dissolved in PBS with 20% methanol or
sera without dilution were applied to a column. After incubation
for 30–60 minutes, the mixture was centrifuged and washed twice
with PBS. Elution was performed with ethyl acetate. The ethyl
acetate elutes were evaporated and the pellets were dissolved in
100% methanol. Inactivated CNBr Sepharose 4B was used as a
control column. We performed the experiments at least 3 times.
Statistics
Data were analyzed by Welch’s t-test and Fisher’s exact test
using a statistical software, JMP version 8.0 (SAS Institute), and P-
values of ,0.05 were considered to be statistically significant.
Results
Activation of HCAECs by KD sera in vitro
Since NOD1 ligand directly activates endothelial cells [8] and
the expression of endothelial activation antigens was detected in
KD skin biopsy specimens [14], HCAECs were employed for the
Figure 2. LC-MS chromatograms and MS/MS fragmentation patterns of serum KD-specific molecules at the 1st study period. A–E:
Each left upper panel: LC-MS chromatograms of KD-specific molecules (A: m/z 1531.8, B: m/z 1414.3, C: m/z 790.9, D: m/z 779.8, and E: m/z 695.0),
Each left lower panel: LC-MS chromatograms of biofilm extracts (or initial culture supernatants) from Y. pseudotuberculosis and S. aureus (A) and B.
cereus (B–E). U: Total ion current chromatograms, M: Extracted-ion chromatograms at m/z 1500–1600 (A), m/z 1400–1500 (B), m/z 700–800 (C and D),
and m/z 600–700 (E), L: Extracted-ion chromatograms at m/z 1531.8 (A), m/z 1414.3 (B), m/z 790.9 (C), m/z 779.8 (D), and m/z 695.0 (E). Arrows
indicate peaks of target molecules. Each right upper panel: MS/MS fragmentation patterns of KD-specific molecules (A: m/z 1531.8, B: m/z 1414.3, C:
m/z 790.9, D: m/z 779.8, and E: m/z 695.0), Each right lower panel: MS/MS fragmentation patterns of biofilm extracts (or initial culture supernatants)
from Y. pseudotuberculosis and S. aureus (A) and B. cereus (B–E). As for the molecule at m/z 779.8, cellobiose lipid shows a MS/MS fragmentation
pattern similar to that of KD sera (D, right lowest panel). The intensity is shown by relative abundance. F: The detection rates of each molecule in NC
(N= 5), DC (N= 41) or KD (N=43) sera are shown. Twenty-one (48.8%) of 43 are positive at m/z 1531.8 (a), 13 (30.2%) of 43 at m/z 1414.3 (b), 17
(39.5%) of 43 at m/z 790.9 (c), 4 (9.3%) of 43 at m/z 779.8 (d) and 15 (34.9%) of 43 at m/z 695.0 (e) when the intensity above 16103 is considered to be
significant. The overall detection rate was 76.7% (33 of 43). P,0.0001 (a, b, c and e); P=0.0364 (d) (Fisher’s exact test).
doi:10.1371/journal.pone.0113054.g002
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search of such molecules as MAMPs in KD sera. KD samples
induced significantly higher IL-8 production than DC and NC
samples in whole sera. After separation into the lipophilic and
hydrophilic fractions with ethyl acetate, KD samples elicited
higher IL-8 production in each fraction (Figure 1). Similar results
were obtained regarding IL-6 production. IL-6 and IL-8 levels in
most of the tested sera from KD patients were under detection
limits or negligible (data not shown). These results suggested that
sera from KD patients contained molecules that stimulated
HCAECs to produce IL-8 and IL-6. NOD1-stimulatory activity
was also examined in whole and fractionated serum samples from
KD, DC and NC, as described in Text S1 in File S1. However, no
NOD1 activity was detected in any of these samples (data not
shown).
Serum KD-specific molecules common to MAMPs from
the in vitro biofilms
We explored serum KD-specific molecules in the lipophilic and
hydrophilic fractions by LC-MS analysis, and found numerous
KD-specific molecules in the lipophilic fractions in 10 KD patients
of the 1st study period (data not shown). It has been reported that
Yersinia (Y.) pseudotuberculosis-infected children sometimes de-
velop KD [15,16]. Moreover, Bacillus (B.) cereus and B. subtilis
were 2 major spore-forming bacteria isolated from KD patients
(Table S1 in File S1), which might work as possible wind-borne
environmental triggers for KD [4]. Therefore, to find out the
MAMPs identical to serum KD-specific molecules, we initially
analyzed culture supernatants (later biofilms) of Y. pseudotubercu-
losis, B. cereus and B. subtilis from KD patients by LC-MS. Five
KD-specific molecules at m/z 1531.8, 1414.3, 790.9, 779.8, and
695.0 showed the m/z and MS/MS fragmentation patterns almost
identical to those of the MAMPs from Y. pseudotuberculosis and B.
cereus (Figure 2 and Figure S1 in File S1). The 5 serum KD-
specific molecules were detected with 100% specificity and 9.3%–
48.8% sensitivity. At least one of the 5 KD-specific molecules was
detected in 33 (76.7%) out of 43 patients at the 1st study period
(Figure 2, Table 1). All serum KD-specific molecules decreased
after IVIG treatment (Figure S1F in File S1). By comparison with
5 authentic microbial glycolipids, only one molecule at m/z 779.8
showed a MS/MS fragmentation pattern similar to that of
cellobiose lipid (Figure 2D).
As these microbes ceased production of these MAMPs after 1 or
2 passages, we investigated the optimal culture conditions
(medium, temperature, duration, shaking, nutrition and biofilm
formation) for the production of these MAMPs. We found that
they produced these MAMPs reproducibly in the biofilm-forming
conditions in the presence of lipid, especially butter (Figure S2 in
File S1). We thus examined the culture supernatants and biofilm
extracts from all the spore-forming microbes isolated from KD
patients as well as additional microbes by LC-MS and MS/MS
analyses. In addition to the 3 bacteria mentioned above, almost all
KD-specific molecules were detected not in the culture superna-
tants but in the biofilm extracts. Although a KD-specific molecule
at m/z 1531.8 was detected in biofilm extracts from several
bacteria (Table S2 in File S1), Y. pseudotuberculosis and
Staphylococcus (S.) aureus were isolated from KD patients. In
addition, B. cereus-associated MAMPs were detected in the sera of
KD patients from whom B. cereus was actually isolated (Figure 2,
Figure S1 in File S1 and Table S1 in File S1).
Serum KD-specific molecules common to MAMPs from
the in vivo biofilms
Although numerous KD-specific molecules were present in the
lipid extracts from KD serum samples of the 2nd study period, the
5 KD-specific MAMPs observed at the 1st study period were no
longer detected in the tested 10 samples. As the number of
oligosaccharides, and the length, position, degree of saturation and
configuration of the hydrophobic moieties in microbial glycolipids
are known to change according to the environmental conditions
and microbial origins [17,18], we examined lipid extracts from the
in vivo biofilms in respective KD patients by LC-MS analysis. We
detected 4 serum KD-specific molecules with MS/MS fragmen-
tation patterns similar to one (m/z 695.0) of the 5 MAMPs at the
1st study period and 3 additional ones in the biofilms formed in
vivo (teeth, tongue, nose and stool), respectively, in 10 (83.3%) out
of 12 KD patients (Table S3 in File S1, Figure 3, Table 1). By the
analysis of 20 microbial biofilm extracts and 5 authentic
glycolipids, only one molecule at m/z 695.0 in tongue biofilms
showed a MS/MS fragmentation pattern similar to that of a
MAMP of B. cereus (Table S2 in File S1).
At the 3rd study period, we examined teeth and tongue biofilms
and found 3 distinct KD-specific molecules with MS/MS
fragmentation patterns similar to those from the in vivo biofilms
in the respective KD patients by LC-MS and MS/MS analyses
(Table S4 in File S1, Figure 4). Two of the 3 serum KD-specific
molecules showed the MS/MS fragmentation patterns similar to a
MAMP from S. aureus, and that from B. subtilis, B. cereus or Y.
pseudotuberculosis, respectively. Actually, B. subtilis and S. aureus
were detected from the patients. At least one of the 3 KD-specific
MAMPs was detected in 10 (90.9%) out of 11 KD patients. The
detection rates of KD-specific serum MAMPs at the 1st, 2nd and
3rd study periods are shown in Table 1. By LC-MS analysis, all the
106 control samples were negative for the 5, 4 and 3 KD-specific
MAMPs detected at the 1st, 2nd and 3rd study periods, respectively.
IgG sepharose binds some serum KD-specific MAMPs
It has been reported that certain microbial glycolipids bound to
various species of IgG [19,20]. Therefore, we checked IgG-
binding activity of KD-specific MAMPs using various kinds of IgG
affinity columns. LC-MS analysis of IgG sepharose-binding
Figure 3. KD in vivo biofilms contain MAMPs common to serum KD-specific molecules (2nd study period). Extensive search for common
molecules in the in vivo biofilms and sera from KD patients or DC controls revealed that 4 KD-specific molecules (m/z 1171.4, 1169.4, 906.8, and 695.0)
showed similar MS/MS fragmentation patterns between the two in KD patients (Table S3 in File S1). A: The molecule at m/z 1171.4 was common in
KD serum and biofilm extracts from teeth, tongue, or nose. B: The molecule at m/z 1169.4 was common in KD serum and stool biofilm extracts. C: The
molecule at m/z 906.8 was common in KD serum and teeth biofilm extracts. D: The molecule at m/z 695.0 was common in KD serum and tongue
biofilm extracts and in vitro biofilm extracts from B. cereus.
doi:10.1371/journal.pone.0113054.g003
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molecules were conducted on KD and DC samples. Three KD-
specific IgG sepharose-binding molecules were detected in KD
sera of the 1st study period. One (m/z 1414.3) of the 5 serum KD-
specific MAMPs (Figure 5A) and 2 other serum KD-specific
MAMPs (m/z 745.6, 733.2) were detected in the IgG sepharose-
binding fractions. The latter two were minor KD-specific MAMPs
because they were detected in KD serum samples only after IgG
sepharose purification. The MS/MS fragmentation patterns of the
3 molecules were similar to those of biofilm lipid extracts from
B.cereus, while that of a molecule at m/z 733.2 also showed some
similarity to that from Y. pseudotuberculosis (Figure S3 in File S1).
To determine the IgG binding region of KD-specific MAMPs,
polyclonal IgG, monoclonal IgG, F(ab9)2, and Fc affinity columns
were employed. Serum KD-specific MAMPs bound to IgG mainly
via Fab non antigen-binding regions (Figure 5B).
Studies on the in vitro biofilm MAMPs from various
microbes
We investigated the stimulatory effects of extracts from culture
supernatants or in vitro biofilms from various microbes on
HCAECs. The biofilm extracts from B. cereus (9 out of 9 strains),
B. subtilis (2 out of 5), Y. pseudotuberculosis (4 out of 4),
Pseudomonas (P.) aeruginosa and S. aureus robustly induced the
production of IL-8 and/or IL-6 by HCAECs, especially when
microbes were cultured in the presence of sterilized butter
(Figure 6). Biofilm extracts from B. cereus, B. subtilis, Y.
pseudotuberculosis, P. aeruginosa and S. aureus were further
fractionated by HPLC. In all of these 5 bacteria, HCAEC-
stimulatory activity was observed in the same fractions (Figure 7).
LC-MS analysis revealed that there were no common MAMPs in
the fractions with high HCAEC-stimulatory activity among the
biofilm extracts from Y. pseudotuberculosis, B. cereus, B. subtilis,
S. aureus and P. aeruginosa.
Discussion
The present study showed that serum KD-specific molecules
had distinct m/z and MS/MS fragmentation patterns in each
temporal clustering of outbreaks. These findings are consistent
with the fact that cases in each cluster share similar clinical
features [21].
At the 1st study period, we detected 5 KD-specific molecules in
patients’ sera that were common to MAMPs from in vitro biofilms
(4 from B. cereus, and 1 from Y. pseudotuberculosis/S. aureus). At
the 2nd and 3rd study periods, we detected 4 and 3 serum KD-
specific molecules in patients’ sera, respectively, common to
MAMPs from in vivo biofilms (1 from B. cereus, 1 from B.
subtilis/B. cereus/Y. pseudotuberculosis, and 1 from S. aureus) in
the respective KD patients. Although Y. pseudotuberculosis is
sometimes involved in KD development [15,16], the detection rate
of Y. pseudotuberculosis-type MAMPs was low in our study.
Rather, B. cereus-type MAMPs were most frequently associated
with KD, and indeed B. cereus itself was isolated from our
patients. In addition, microbes producing B. subtilis-type and S.
aureus-type MAMPs were also associated with KD.
B. cereus, B. subtilis, Y. pseudotuberculosis, S. aureus, and P.
aeruginosa produced endothelial cell-activating MAMPs only in
the biofilm-forming conditions, mostly in higher amounts in the
presence of butter (Figure 6). Four of the 5 bacteria were isolated
from our KD patients, and P. aeruginosa was associated with KD
development [22] and isolated from the small intestine of KD
patients [23].
The biofilm formation may be found in living tissues including
teeth, tongue, respiratory tract, middle ears, and gastrointestinal
tract [24]. In KD, specific MAMPs were detected in sera as well as
in the in vivo biofilm extracts from various sites by LC-MS
analysis. Several molecules common to both KD patients’ in vivo
biofilms and sera were not present in the in vitro biofilm extracts of
a single microbe, probably because they were products from
polymicrobial biofilms in vivo [25]. The transition from the
planktonic state to the sessile state in the biofilm induces a radical
change in the gene and protein expression in bacteria. The biofilm
matrix, composed of polysaccharides, proteins, nucleic acids and
lipids, is newly produced and secreted to form the immediate
extracellular environment [26]. Indeed, bacterial biofilm products
were reported to induce a distinct inflammatory response in
human cells compared to their planktonic counterparts [27]. In
our study, not culture supernatants but biofilm extracts induced
cytokine production in human endothelial cells (Figure 6).
Bacillus species including B. cereus and B. subtilis are volatile
spore-forming rods widely distributed in soil and air, and
sometimes induce infections and intoxications [28,29]. The
necessity of the biofilm and a certain environmental condition
might explain why the presence of Bacillus species in control
individuals does not induce KD by itself, and why other types of
Bacillus species infections such as bacteremia and meningitis are
not associated with KD development. In addition, just like KD [2],
there is no person to person transmission in Bacillus species-
associated human diseases such as food poisoning [28] and
anthrax [30].
At least some serum KD-specific MAMPs bound to IgG mainly
via Fab non antigen-binding regions, just like other microbial
glycolipids that showed a high binding affinity to human IgG via
Fab constant regions [19,20]. Therefore, it is likely that high-dose
IVIGs work, at least in part, as a scavenger of such MAMPs from
the blood stream, a previously unrecognized mechanism in KD
[31,32].
The main limitations of our study were that the structural
analysis of these KD-specific MAMPs was hampered by the
instability of the lipophilic molecules after purification, and that
Figure 4. KD in vivo biofilms contain MAMPs common to serum KD-specific molecules (3rd study period). Three serum KD-specific
molecules (m/z 667.4, 619.4 and 409.3) at the 3rd study showed the same m/z with MS/MS fragmentation patterns similar to MAMPs from in vivo
biofilm extracts (Table S4 in File S1) and in vitro bacterial biofilm extracts. A: The molecule at m/z 667.4 was common in KD serum, tongue biofilm
extracts and in vitro biofilm extracts from S. aureus. B: The molecule at m/z 619.4 was common in KD serum, teeth and tongue biofilm extracts, and in
vitro biofilm extracts from B. subtilis, B. cereus and Y. pseudotuberculosis. C: The molecule at m/z 409.3 was common in KD serum, and teeth and
tongue biofilm extracts.
doi:10.1371/journal.pone.0113054.g004
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Figure 5. LC-MS chromatograms of IgG sepharose-binding molecules. A. Representative LC-MS chromatograms of a IgG sepharose-binding
molecule (m/z 1414.3) are shown in a KD patient and a DC control. TIC: Total ion current chromatograms, XIC: Extracted-ion chromatograms at m/z
1400–1500, and extracted-ion chromatograms at m/z 1414.3. (1) Human polyclonal IgG-conjugated sepharose 6 Fast (2) Inactivated CNBr Sepharose
4B control column. B. Binding of a KD-specific molecule to various affinity columns: Columns used are described in ONLINE METHODS. +: The binding
quantities of a KD-specific molecule analyzed by LC-MS were equal or larger than those to human polyclonal IgG column, 6: smaller than 20% of
those to human polyclonal IgG column, -: no binding. We performed the experiments 3 times.
doi:10.1371/journal.pone.0113054.g005
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fractionated crude biofilm extracts were too toxic to replicate the
KD phenotype in mice.
We have shown that serum KD-specific molecules were diverse
but mostly derived from biofilms and possessed molecular
structures common to MAMPs. The present study suggests a
possibility that KD-specific MAMPs induce vascular inflamma-
tion, leading to the development of KD. Further study is on the
way as a nation-wide project to investigate a pathogenic link
between KD development and biofilm-derived MAMPs.
Conclusion
Extensive analysis by LC-MS/MS revealed that serum KD-
specific molecules possessed molecular structures common to
MAMPs from Bacillus cereus, Bacillus subtilis, Yersinia pseudo-
tuberculosis and Staphylococcus aureus. These molecules were
mostly derived from biofilms formed in vivo (teeth, tongue, nasal
cavity, or stool). This report might offer novel insight into the
diagnosis and management of KD as well as its pathogenesis.
Figure 6. Activation of HCAECs by biofilm lipid extracts from various microbes. The production of IL-6 and IL-8 by HCAECs was measured
after 24-h culture in the presence or absence of a microbial stimulant. Each microbe was cultured in the presence or absence of biofilm-forming glass
slides with or without butter. As a microbial stimulant, an extract from a culture supernatant (%) or a biofilm (&) of a microbe cultured in the
presence (right column) or absence (left column) of butter was used. Medium alone, ethyl acetate alone or ethyl acetate extract from glass slides
cultured in the absence of a microbe was used as a negative control (NC). FK 565 (10 mg/mL) was used as a positive control (PC). B.c: Bacillus cereus,
B.s: Bacillus subtilis, G.t: Gordonia terrae, T.s: Terribacillus saccharophilus, S.f: Streptomyces flavogriseus, S.v: Streptomyces violaceus, Y.p: Yersinia
pseudotuberculosis, Y.e: Yersinia enterocolitica, E.c: Escherichia coli, P.ae: Pseudomonas aeruginosa, S.a: Staphylococcus aureus, S.e: Staphylococcus
epidermidis, S.p: Streptococcus pyogenes, S.m: Streptococcus mitis, S.s: Streptococcus sanguinis, P.ac: Propionibacterium acnes, A.n: Aspergillus niger, C.a:
Candida albicans, U.m: Ustilago maydis, P.o: Penicillium oxalicum. Numbers under bacteria indicate those of KD patients. Data are expressed as the fold
change induction of IL-8 or IL-6 compared to the PC levels. We performed the experiments 3 times. Biofilms were compared with supernatant control
considering presence or absence of butter. *P,0.01, **P,0.001 and ***P,0.0001 (Welch’s t-test).
doi:10.1371/journal.pone.0113054.g006
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Figure 7. Fractionation of HCAEC-activating biofilm lipid extracts by HPLC. Each biofilm lipid extract from Y. pseudotuberculosis (A), B.
cereus (B), B. subtilis (C), S. aureus (D) or P. aeruginosa (E) was separated into 10 fractions by HPLC and assayed for the stimulatory activity of HCAECs
(&). Fractions 3 and 4 from each biofilm lipid extract induced high cytokine production by HCAECs. Ethyl acetate lipid extracts from glass slides in the
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